Growing evidence demonstrating the role of Hippo signaling in cancer biology and the lack of efficient treatments for glioblastoma support the idea that Hippo effectors YAP/TAZ-TEADs could represent potential targets paving the way for alternative therapeutics. This evidence concerns the gene YAP1 and cancer.